General Information

Ceapro Inc.

	Address	22 Adelaide St W Suite 3400 Toronto, M5H 4E3 Canada
	Address type	Registered Office Address
	Address province	Ontario

	Corporation ID	9690077
	Business number	887207280
	Status	Active
	ACT	Canada Business Corporations Act
	Anniversary date	04/01/2016
	Last annual filing	2026
	Data verified	10/31/2026

Description

Ceapro Inc. is an active company which was registered under Canada Business Corporations Act with a corporation number 9690077 (business no 887207280). The amalgamation was conducted on 2016-04-01. The company is based in Toronto at 22 Adelaide St W, Suite 3400, M5H 4E3 in Ontario area. To our knowledge, the latest annual meeting took place on 2016-06-01.
Additional corporations in the vicinity include: Green Future Energy Solutions Ltd., 7306849 Canada Corp., 10019321 Canada Inc., Init Innovations In Transportation (Western Canada) Inc., Renano Holdings Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name	Effective date	Type	Current
CEAPRO INC.	04/01/2016	Corporate Name	true

Directors

Glenn Rourke
,

Donald Oborowsky
,

Gilles Gagnon
,

Ulrich Kosciessa
,

John Zupancic
,

William W. Li
,

last updated: 2026-10-30

Government Grants and Contributions

2 federal grants and contributions between 2019 and 2021 with a total value of $1,070,000.

Start date	Department and program	Value
11/01/2021	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Boosting Innovation Capacity of PGX Technology Towards Pharmaceutical Applications Ceapro will further develop the Pressurized Gas eXpanded (PGX) platform technology by designing a pharmaceutical PGX processing unit and bioactive impregnation and loading units. These new units will be used to generate active pharmaceutical ingredients for trials required to confirm...	$480,000
07/16/2019	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Positioning Canadian Innovation on a Global Stage using Ceapro’s Disruptive PGX Platform Technology The Pressurized Gas eXpanded (PGX) Technology is a patented platform technology for the generation of fine-structured, open-porous, water-soluble biopolymer carriers for tailor-made bioactive or drug delivery systems. Ceapro will further develop the patented PGX Technology by upgrading the PGX...	$590,000

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
04/01/2016	Amalgamation	2

Company annual return

Meeting date	Type of corporation	Year of filing
06/01/2016	Distributing corporation	2017

Companies nearby